Miv Therapeutics, Inc. (IVT) Tops Q2 EPS by 1c

Go back to Miv Therapeutics, Inc. (IVT) Tops Q2 EPS by 1c

InvenTrust Properties Corp. Reports 2023 Second Quarter Results

July 31, 2023 4:05 PM EDT

DOWNERS GROVE, III.--(BUSINESS WIRE)-- InvenTrust Properties Corp. (InvenTrust or the Company) (NYSE: IVT) today reported financial and operating results for the period ended June 30, 2023. For the three months ended June 30, 2023 and 2022, Net Income was $2.1 million, or $0.03 per diluted share, compared to Net Income of $41.9 million, or $0.62 per diluted share, respectively.

Second Quarter 2023 Highlights:

NAREIT FFO of $0.43 per diluted share Core FFO of $0.43 per diluted share Same Property Net Operating Income (NOI) growth of 3.7% Leased Occupancy as of June 30, 2023... More